CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of September 2026 for CollPlant Biotechnologies Ltd., a foreign private issuer. The report discloses a corporate governance update following the closing of the Lightsolver acquisition.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
The primary material change disclosed is the appointment of Dr. Ruti Ben Shlomi to the Company's Board of Directors. This appointment occurred following the closing of the acquisition of Lightsolver.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on future performance, or specific risk factors. The document serves solely to incorporate a press release regarding the board appointment by reference.
Key Facts for Investor Verification
- Dr. Ruti Ben Shlomi has been appointed to the Board of Directors.
- The appointment follows the closing of the Lightsolver acquisition.
- The press release detailing this event is attached as Exhibit 99.1.
- No financial performance data is included in this specific filing.